Covaxa: Shareholder inquiry transfer preliminary pricing at 30.88 yuan per share.

Kexing Pharmaceutical announced that based on the inquiry and subscription situation on September 15, 2025, the preliminary determined transfer price for this inquiry is 30.88 yuan per share. There were a total of 21 institutional investors participating in the bidding and subscription, with a total of 10,190,000 shares effectively subscribed, corresponding to an effective subscription multiple of 1.01 times. The shares to be transferred in this inquiry have been fully subscribed, and the preliminary identified transferees are 21 institutional investors, with a total of 10,062,800 shares to be transferred.